WallStreetZenWallStreetZen

NASDAQ: INNV
Innovage Holding Corp Stock Forecast, Predictions & Price Target

Analyst price target for INNV

Based on 2 analysts offering 12 month price targets for Innovage Holding Corp.
Min Forecast
$6.00+16.05%
Avg Forecast
$6.50+25.73%
Max Forecast
$7.00+35.4%

Should I buy or sell INNV stock?

Based on 2 analysts offering ratings for Innovage Holding Corp.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INNV stock forecasts and price targets.

INNV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-08

1 of 1

Forecast return on equity

Is INNV forecast to generate an efficient return?
Company
4.35%
Industry
-167.73%
Market
62.59%
INNV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INNV forecast to generate an efficient return on assets?
Company
2.32%
Industry
7.97%
INNV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INNV earnings per share forecast

What is INNV's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
$0.00
Avg 3 year Forecast
$0.09

INNV revenue forecast

What is INNV's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$754.7M+1.8%
Avg 2 year Forecast
$841.7M+13.54%
Avg 3 year Forecast
$948.8M+27.99%
INNV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INNV revenue growth forecast

How is INNV forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
6.92%
Industry
5.17%
Market
9.16%
INNV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INNV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INNV vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
INNV$5.17$6.50+25.73%Hold
PNTG$23.30$24.00+3.00%Buy
HCSG$10.52$14.50+37.83%Buy
MD$7.10$9.00+26.76%Hold
AUNA$7.73$14.15+83.05%Strong Buy

Innovage Holding Stock Forecast FAQ

Is Innovage Holding Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: INNV) stock is to Hold INNV stock.

Out of 2 analysts, 0 (0%) are recommending INNV as a Strong Buy, 0 (0%) are recommending INNV as a Buy, 2 (100%) are recommending INNV as a Hold, 0 (0%) are recommending INNV as a Sell, and 0 (0%) are recommending INNV as a Strong Sell.

If you're new to stock investing, here's how to buy Innovage Holding stock.

What is INNV's earnings growth forecast for 2024-2026?

(NASDAQ: INNV) Innovage Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 22.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.14%.

Innovage Holding's earnings in 2024 is -$30,815,000.On average, 2 Wall Street analysts forecast INNV's earnings for 2024 to be -$22,437,956, with the lowest INNV earnings forecast at -$24,477,771, and the highest INNV earnings forecast at -$20,398,142. On average, 2 Wall Street analysts forecast INNV's earnings for 2025 to be $0, with the lowest INNV earnings forecast at -$1,359,876, and the highest INNV earnings forecast at $1,359,876.

In 2026, INNV is forecast to generate $12,238,885 in earnings, with the lowest earnings forecast at $12,238,885 and the highest earnings forecast at $12,238,885.

What is INNV's revenue growth forecast for 2024-2026?

(NASDAQ: INNV) Innovage Holding's forecast annual revenue growth rate of 6.92% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.16%.

Innovage Holding's revenue in 2024 is $741,328,000.On average, 2 Wall Street analysts forecast INNV's revenue for 2024 to be $102,624,413,536, with the lowest INNV revenue forecast at $102,493,865,426, and the highest INNV revenue forecast at $102,754,961,646. On average, 2 Wall Street analysts forecast INNV's revenue for 2025 to be $114,462,815,360, with the lowest INNV revenue forecast at $114,338,386,692, and the highest INNV revenue forecast at $114,587,244,027.

In 2026, INNV is forecast to generate $129,023,689,236 in revenue, with the lowest revenue forecast at $129,023,689,236 and the highest revenue forecast at $129,023,689,236.

What is INNV's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: INNV) forecast ROA is 2.32%, which is lower than the forecast US Medical Care Facilities industry average of 7.97%.

What is INNV's Price Target?

According to 2 Wall Street analysts that have issued a 1 year INNV price target, the average INNV price target is $6.50, with the highest INNV stock price forecast at $7.00 and the lowest INNV stock price forecast at $6.00.

On average, Wall Street analysts predict that Innovage Holding's share price could reach $6.50 by Mar 13, 2025. The average Innovage Holding stock price prediction forecasts a potential upside of 25.73% from the current INNV share price of $5.17.

What is INNV's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: INNV) Innovage Holding's current Earnings Per Share (EPS) is -$0.23. On average, analysts forecast that INNV's EPS will be -$0.17 for 2024, with the lowest EPS forecast at -$0.18, and the highest EPS forecast at -$0.15. On average, analysts forecast that INNV's EPS will be $0.00 for 2025, with the lowest EPS forecast at -$0.01, and the highest EPS forecast at $0.01. In 2026, INNV's EPS is forecast to hit $0.09 (min: $0.09, max: $0.09).

What is INNV's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: INNV) forecast ROE is 4.35%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.